Search research articles
Contact Us
Filters
Showing results (101-110 of 159) with videos related to
Page
of 16
Sort By:
Mayo Clinic Proceedings
|
March 1, 1977
Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease
M D Muenter, N S Sharpless, G M Tyce, et al.
The American Journal of Physiology
|
August 1, 1993
Free and conjugated catecholamines and serotonin in canine thoracic duct lymph: effects of feeding
Y K Chen, H M Richter, V L Go, et al.
Peptides
|
May 1, 1989
Adrenal vein catecholamines and neuropeptides during splanchnic nerve stimulation in cats
D M Gaumann, T L Yaksh, G M Tyce, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1974
Dopa, 3-O-methyldopa, and metabolites in urine during oral L-3-O-methyldopa therapy
N S Sharpless, G M Tyce, M D Muenter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 1, 1972
3-methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease
N S Sharpless, M D Muenter, G M Tyce, et al.
The American Journal of Cardiology
|
August 1, 1972
Pheochromocytoma. Fine structural, biochemical and clinical observations
N T Lauper, G M Tyce, S G Sheps, et al.
Journal of Neurochemistry
|
May 1, 1990
Precursors and metabolites of norepinephrine in sympathetic ganglia of the dog
E W Kristensen, S L Chinnow, R S Montreuil, et al.
Circulatory Shock
|
February 1, 1989
Adrenal vein catecholamines and met-enkephalin during staged hemorrhage and naltrexone administration in cats
D M Gaumann, T L Yaksh, M K Dousa, et al.
The American Journal of Physiology
|
November 24, 1999
Chronic oral L-DOPA increases dopamine and decreases serotonin excretions
N H García, T J Berndt, G M Tyce, et al.
Journal of Neurochemistry
|
January 1, 1985
Free and conjugated amines in human lumbar cerebrospinal fluid
G M Tyce, D K Rorie, D E Byer, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 159) with videos related to
Sort By:
Page
of 16
Mayo Clinic Proceedings
|
March 1, 1977
Patterns of dystonia ("I-D-I" and "D-I-D-") in response to l-dopa therapy for Parkinson's disease
M D Muenter, N S Sharpless, G M Tyce, et al.
The American Journal of Physiology
|
August 1, 1993
Free and conjugated catecholamines and serotonin in canine thoracic duct lymph: effects of feeding
Y K Chen, H M Richter, V L Go, et al.
Peptides
|
May 1, 1989
Adrenal vein catecholamines and neuropeptides during splanchnic nerve stimulation in cats
D M Gaumann, T L Yaksh, G M Tyce, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1974
Dopa, 3-O-methyldopa, and metabolites in urine during oral L-3-O-methyldopa therapy
N S Sharpless, G M Tyce, M D Muenter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
March 1, 1972
3-methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease
N S Sharpless, M D Muenter, G M Tyce, et al.
The American Journal of Cardiology
|
August 1, 1972
Pheochromocytoma. Fine structural, biochemical and clinical observations
N T Lauper, G M Tyce, S G Sheps, et al.
Journal of Neurochemistry
|
May 1, 1990
Precursors and metabolites of norepinephrine in sympathetic ganglia of the dog
E W Kristensen, S L Chinnow, R S Montreuil, et al.
Circulatory Shock
|
February 1, 1989
Adrenal vein catecholamines and met-enkephalin during staged hemorrhage and naltrexone administration in cats
D M Gaumann, T L Yaksh, M K Dousa, et al.
The American Journal of Physiology
|
November 24, 1999
Chronic oral L-DOPA increases dopamine and decreases serotonin excretions
N H García, T J Berndt, G M Tyce, et al.
Journal of Neurochemistry
|
January 1, 1985
Free and conjugated amines in human lumbar cerebrospinal fluid
G M Tyce, D K Rorie, D E Byer, et al.
Page
of 16